Guidance

Influenza: antiviral susceptibility surveillance and diagnosis of resistance

Summarises incidence and mechanisms of NAI resistance in seasonal influenza viruses and availability of NAI susceptibility testing in UK.

Documents

Surveillance and laboratory testing of influenza neuraminidase inhibitor resistance

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This information is for laboratory scientists, clinicians and public health practitioners with responsibility for influenza virus diagnostic testing, the management of patients receiving neuraminidase inhibitor (NAI) prophylaxis or treatment or investigation of influenza virus outbreaks.

Published 17 October 2011
Last updated 2 December 2016 + show all updates
  1. Updated with latest guidance.
  2. First published.